Live from the NIH registry
Studies recruiting near Victorville right now
Top 25 of 48 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart Failure, Left Ventricular Systolic Dysfunction
Phase 2, Phase 3
Interventional 342 participants sought
Loma Linda University Health System ( Site 0008) — San Bernardino, California (29.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
National Institute of Clinical Research, Inc — Victorville, California (3.6 mi)
· Sponsor: CSL Behring
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Rialto, California (29.1 mi)
· Sponsor: Hoffmann-La Roche
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Lupus Erythematosus, Systemic, Lupus Nephritis
Phase 2
Interventional 179 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Velocity Clinical Research- Banning — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Velocity Clinical Research — San Bernardino, California (29.2 mi)
· Sponsor: vTv Therapeutics
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Hepatic Impairment, Cirrhosis
Phase 1
Interventional 144 participants sought
Inland Empire Clinical Trials — Rialto, California (29.1 mi)
· Sponsor: Vir Biotechnology, Inc.
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Kidney Disease, Peritoneal Dialysis (PD)
N/A
Observational 125 participants sought
Desert Cities Dialysis — Victorville, California (3.6 mi)
· Sponsor: Bodyport Inc.
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Phase 2
Interventional 240 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluating the Impact of Training for IHSS Workers
Home Care for Elderly or Disabled Individuals
N/A
Interventional 2,500 participants sought
San Bernardino County — San Bernardino, California (29.2 mi)
· Sponsor: Abdul Latif Jameel Poverty Action Lab
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Psoriatic Arthritis, Axial Spondyloarthritis
Phase 1
Interventional 392 participants sought
Pa0019 127 — Apple Valley, California (9.7 mi)
· Sponsor: UCB Biopharma SRL
Pompe Disease Registry Protocol
Glycogen Storage Disease Type II, Pompe Disease
N/A
Observational 2,000 participants sought
Loma Linda University Children'S Hospital- Site Number : 840117 — San Bernardino, California (29.2 mi)
· Sponsor: Genzyme, a Sanofi Company
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pediatric Migraine
Phase 3
Interventional 2,100 participants sought
Velocity Clinical Research, San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Pfizer
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Victorville, California (3.6 mi)
· Sponsor: AstraZeneca
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
Moderate Hepatic Impairment
Phase 1
Interventional 20 participants sought
Research Site — Rialto, California (29.1 mi)
· Sponsor: AstraZeneca
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Site US10008 — San Bernardino, California (29.2 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Non-alcoholic Fatty Liver Disease
Phase 1
Interventional 32 participants sought
GSK Investigational Site — Rialto, California (29.1 mi)
· Sponsor: GlaxoSmithKline
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Proteinuric Kidney Disease
Phase 2, Phase 3
Interventional 466 participants sought
Kidney and Hypertension Center — Victorville, California (3.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Overweight or Obesity and Elevated Liver Fat
Phase 2
Interventional 180 participants sought
Inland Empire Liver Foundation — Rialto, California (29.1 mi)
· Sponsor: Amgen
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
Autoimmune Hepatitis, AIH
Phase 3
Interventional 180 participants sought
Inland Empire Liver Foundation — Rialto, California (29.1 mi)
· Sponsor: Amgen
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC
Functional Constipation (FC)
Phase 2
Interventional 180 participants sought
Loma Linda University — San Bernardino, California (29.2 mi)
· Sponsor: Bausch Health Americas, Inc.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Om Research LLC — Apple Valley, California (9.7 mi)
· Sponsor: Hoffmann-La Roche
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Velocity Clinical Research -San Bernardino — San Bernardino, California (29.2 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Victorville, California (3.6 mi)
· Sponsor: Hoffmann-La Roche